Bacteriophages and their potential for treatment of gastrointestinal diseases

Nat Rev Gastroenterol Hepatol. 2022 Feb;19(2):135-144. doi: 10.1038/s41575-021-00536-z. Epub 2021 Nov 15.

Abstract

Although bacteriophages have been overshadowed as therapeutic agents by antibiotics for decades, the emergence of multidrug-resistant bacteria and a better understanding of the role of the gut microbiota in human health and disease have brought them back into focus. In this Perspective, we briefly introduce basic phage biology and summarize recent discoveries about phages in relation to their role in the gut microbiota and gastrointestinal diseases, such as inflammatory bowel disease and chronic liver disease. In addition, we review preclinical studies and clinical trials of phage therapy for enteric disease and explore current challenges and potential future directions.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Review

MeSH terms

  • Bacteriophages / physiology*
  • Gastrointestinal Diseases / etiology*
  • Gastrointestinal Diseases / therapy*
  • Gastrointestinal Microbiome / physiology*
  • Humans